{"id":14549,"date":"2021-09-16T12:56:50","date_gmt":"2021-09-16T12:56:50","guid":{"rendered":"https:\/\/haberglobal.com.tr\/gundem\/turkiye-de-ucuncu-doz-sonuclari-ilk-kez-aciklandi-coronavac-yaptiranda-7-5-biontech-yaptiranda-106-kat-artti-133024"},"modified":"2021-09-16T12:56:50","modified_gmt":"2021-09-16T12:56:50","slug":"turkiyede-ucuncu-doz-sonuclari-ilk-kez-aciklandi-coronavac-yaptiranda-7-5-biontech-yaptiranda-106-kat-artti","status":"publish","type":"post","link":"https:\/\/istanbulchannel.net\/index.php\/2021\/09\/16\/turkiyede-ucuncu-doz-sonuclari-ilk-kez-aciklandi-coronavac-yaptiranda-7-5-biontech-yaptiranda-106-kat-artti\/","title":{"rendered":"T\u00fcrkiye’de \u00fc\u00e7\u00fcnc\u00fc doz sonu\u00e7lar\u0131 ilk kez a\u00e7\u0131kland\u0131: Coronavac yapt\u0131randa 7.5, BioNTech yapt\u0131randa 106 kat artt\u0131"},"content":{"rendered":"
<\/div>\n
<\/div>\n

Koronavir\u00fcs pandemisi tedbirleri kapsam\u0131nda ilk 2 dozu \u00c7inli Sinovac \u015firketinin geli\u015ftidi\u011fi Coronavac a\u015f\u0131s\u0131 olanlara 3. doz a\u015f\u0131 uygulamas\u0131 s\u00fcrerken Dokuz Eyl\u00fcl \u00dcniversitesi, 3. doz a\u015f\u0131 olan sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n\u0131n antikor oranlar\u0131n\u0131 bas\u0131n mensuplar\u0131 ile payla\u015ft\u0131.<\/p>\n

Maddeler halinde ara\u015ft\u0131rman\u0131n sonucu hakk\u0131nda rakamlar veren Hotar, \u015fu bilgileri payla\u015ft\u0131: <\/p>\n

\u201cAra\u015ft\u0131rmam\u0131z\u0131n ilk sonu\u00e7lar\u0131na g\u00f6re antikor d\u00fczeylerinin Dokuz Eyl\u00fcl \u00dcniversitesi sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n\u0131n iki doz Coronavac a\u015f\u0131s\u0131ndan 4 ay sonra anlaml\u0131 \u015fekilde d\u00fc\u015ft\u00fc\u011f\u00fc ancak y\u00fczde 89\u2019unda halen yeterli d\u00fczeyde oldu\u011funu tespit etti \u00e7al\u0131\u015fan arkada\u015flar\u0131m\u0131z. \u00dc\u00e7\u00fcnc\u00fc doz a\u015f\u0131 sonras\u0131 sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n\u0131n y\u00fczde 100\u2019\u00fcnde antikor d\u00fczeyinin artt\u0131\u011f\u0131 ve yeterli d\u00fczeye eri\u015fti\u011fi saptand\u0131. Sa\u011fl\u0131k personelinin 3. doz a\u015f\u0131s\u0131n\u0131 Coronavac olarak yapt\u0131ranlarda a\u015f\u0131dan en az 7 g\u00fcn sonra antikor d\u00fczeyinin 7,5 kat artt\u0131\u011f\u0131, BioNTech olarak yapt\u0131ranlarda ise 106 kat artt\u0131\u011f\u0131 tespit edildi.”<\/p>\n

SADECE 1 K\u0130\u015e\u0130 KORONAV\u0130R\u00dcSE YAKALANDI<\/strong><\/p>\n

“Kat\u0131l\u0131mc\u0131lardan 3. doz a\u015f\u0131s\u0131n\u0131 BioNTech ile olanlar\u0131n durumlar\u0131 de\u011ferlendirildi\u011finde antikor d\u00fczeylerinin zaman i\u00e7inde d\u00fc\u015ft\u00fc\u011f\u00fc, ancak halen var olan antikor d\u00fczeyinin a\u015f\u0131dan yakla\u015f\u0131k iki ay sonra olduk\u00e7a yeterli d\u00fczeyde oldu\u011fu (16865 AU\/ml) saptand\u0131. A\u015f\u0131dan sonra y\u00fczde 100 artt\u0131 ancak d\u00fc\u015fmesine ra\u011fmen 2 ay ge\u00e7mesine ra\u011fmen hala yeterli koruma sa\u011fland\u0131\u011f\u0131 g\u00f6r\u00fcld\u00fc. \u0130lk iki doz a\u015f\u0131 aras\u0131nda sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131n y\u00fczde 4\u2019\u00fcnde koronavir\u00fcs hastal\u0131\u011f\u0131 geli\u015fti\u011fi g\u00f6r\u00fcnd\u00fc. 3. doz a\u015f\u0131s\u0131n\u0131 olan 293 ki\u015fiden sadece 1 ki\u015fide koronavir\u00fcse yakaland\u0131 ve o da hafif atlatt\u0131.\u201d<\/p>\n

A\u015f\u0131 kar\u015f\u0131tlar\u0131 i\u00e7in su\u00e7 duyurusunda bulunulabilece\u011fini de belirten Hotar, \u201cKi\u015filer kendi \u00f6zg\u00fcrl\u00fck alan\u0131 i\u00e7inde b\u00f6yle bir \u00f6zg\u00fcrl\u00fck hakk\u0131n\u0131 sahip olsalar bile ki sadece kendileri bir adada ya\u015f\u0131yorsa bu \u00f6zg\u00fcrl\u00fcklerini kullanabilirler. Ancak her bir ki\u015fi \u00e7al\u0131\u015fma arkada\u015flar\u0131n\u0131 riske att\u0131\u011f\u0131 i\u00e7in bu bir \u00f6zg\u00fcrl\u00fck de\u011fil. Kitleleri engelleyecek a\u015f\u0131 kar\u015f\u0131tlar\u0131na kar\u015f\u0131 bir su\u00e7 duyurunda bulunabilir toplumu riske att\u0131\u011f\u0131 i\u00e7in\u201d \u015feklinde konu\u015ftu.<\/p>\n

 Dokuz Eyl\u00fcl \u00dcniversitesi b\u00fcnyesinde yer alan \u00f6\u011fretim \u00fcyelerinin \u00e7o\u011funlu\u011funun a\u015f\u0131land\u0131\u011f\u0131n\u0131 belirten Hotar, \u201cHocalar\u0131m\u0131z i\u00e7i \u00e7ok ciddi bir a\u015f\u0131lanma oran\u0131 var. Olmayanlardan da haftada 2 kere PCR testi isteyece\u011fiz. \u00d6\u011frenciler i\u00e7in turnike say\u0131lar\u0131m\u0131z\u0131 artt\u0131r\u0131yoruz, g\u00fcvenlik say\u0131m\u0131z\u0131 artt\u0131r\u0131yoruz, giri\u015flerimiz artt\u0131r\u0131yoruz ki hem de a\u015f\u0131 hem de test sonu\u00e7lar\u0131n\u0131 her g\u00fcn kontrol edebilirim\u201d dedi.<\/p>\n

Okullar a\u00e7\u0131klamas\u0131 ile a\u015f\u0131lanma say\u0131lar\u0131n\u0131n de\u011fi\u015fece\u011fini belirten Hotar, \u201cBen a\u015f\u0131s\u0131z \u00f6\u011frenci rakam\u0131n\u0131n 0\u2019a yak\u0131n olaca\u011f\u0131n\u0131 d\u00fc\u015f\u00fcn\u00fcyorum. Toplumu a\u015f\u0131 kar\u015f\u0131t\u0131 s\u00f6ylemi etkilemekte. Vatanda\u015flar\u0131m\u0131z duyarl\u0131l\u0131k g\u00f6sterip bunlara kar\u015f\u0131 bir tepki ortaya koymas\u0131 laz\u0131m. Kendisini tamam ama ba\u015fkas\u0131n\u0131 riske atamaz\u201d a\u00e7\u0131klamas\u0131nda bulundu.<\/p>\n

“\u015eU ANK\u0130 VER\u0130LERE G\u00d6RE 3. OLARAK B\u0130R DOZ BIONTECH A\u015eISI YETER”<\/strong><\/p>\n

Halk Sa\u011fl\u0131\u011f\u0131 Ana Bilim Dal\u0131 Ba\u015fkan\u0131 Prof. Dr. B\u00fclent K\u0131l\u0131\u00e7 ise \u00e7al\u0131\u015fman\u0131n \u00f6nemine de\u011finerek, \u015funlar\u0131 ifade etti:<\/p>\n

\u201cSa\u011fl\u0131k \u00e7al\u0131\u015fanlarda ve belli bir ya\u015f gurubunda 2 doz Sinovac a\u015f\u0131s\u0131ndan sonra bir doz Mrna a\u015f\u0131s\u0131 yap\u0131lan bir grup var. Bununla ilgili sonu\u00e7lar bilinmiyor. B\u00fct\u00fcn d\u00fcnyada bilinmiyor. T\u00fcrkiye\u2019de de bu konuda ba\u015flayan \u00e7al\u0131\u015fmalar var ama sonucu ilk a\u00e7\u0131klayan biziz. D\u00fcnyada ve T\u00fcrkiye\u2019de ilk kez 2 doz inaktif a\u015f\u0131dan sonra 1 Mrna a\u015f\u0131s\u0131 yap\u0131lanlarda bir sonu\u00e7 a\u00e7\u0131klan\u0131yor. \u20182 doz Coronavac a\u015f\u0131lar\u0131n\u0131n hi\u00e7bir etkisi yok, mutlaka herkese s\u0131f\u0131rdan BioNTech yapal\u0131m\u2019 diye bir d\u00fc\u015f\u00fcnce vard\u0131. Ama daha \u00f6nce yap\u0131lan a\u015f\u0131lar\u0131n bir yarar\u0131 oldu\u011funu ve 3. doz olarak tek doz Mrna a\u015f\u0131s\u0131 yap\u0131lmas\u0131yla bile \u00e7ok y\u00fcksek miktarda antikor olu\u015ftu\u011funu g\u00f6steriyor.”<\/p>\n

“O d\u00fc\u015f\u00fcnce b\u00f6ylelikle yok olmu\u015f oldu. Y\u00fcksek antikor olu\u015fuyor. \u2018Daha \u00f6nce yap\u0131lan Coronvac yok say\u0131l\u0131r, 2 doz BioNTech a\u015f\u0131s\u0131 yap\u0131l\u0131r\u2019 d\u00fc\u015f\u00fcncesi yanl\u0131\u015f. Biz yakla\u015f\u0131k 2 ayd\u0131r bu durumu izliyoruz. \u015eu anki verilere g\u00f6re 3. olarak bir doz BioNTech a\u015f\u0131s\u0131 yeter. Biz Aral\u0131k ay\u0131nda tekrar bir izleme yapaca\u011f\u0131z. \u00c7\u00fcnk\u00fc antikor d\u00fczeyleri d\u00fc\u015febilir. Ama bir sorun olaca\u011f\u0131n\u0131 d\u00fc\u015f\u00fcnm\u00fcyoruz. Biz zaten hastal\u0131\u011fa yakalananlar\u0131 izliyoruz. Bizim durumumuzda hastal\u0131\u011fa yakalanan \u00e7ok az ki\u015fi var. 300 ki\u015fiden 1 ki\u015fi hastal\u0131\u011fa yakaland\u0131. Hastal\u0131\u011fa yakalanmaktan koruyor, 2. bir Mrna a\u015f\u0131s\u0131na gerek olup olmad\u0131\u011f\u0131n\u0131 ara\u015ft\u0131r\u0131yoruz.\u201d<\/p>\n

Kaynak: \u0130HA<\/p>\n","protected":false},"excerpt":{"rendered":"

<p>Koronavir\u00fcs pandemisi tedbirleri kapsam\u0131nda ilk 2 dozu \u00c7inli Sinovac \u015firketinin geli\u015ftidi\u011fi Coronavac a\u015f\u0131s\u0131 olanlara 3. doz a\u015f\u0131 uygulamas\u0131 s\u00fcrerken Dokuz Eyl\u00fcl…<\/p>\n","protected":false},"author":2,"featured_media":14550,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,15],"tags":[],"class_list":["post-14549","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gundem","category-turkiye"],"_links":{"self":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/14549","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/comments?post=14549"}],"version-history":[{"count":0,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/14549\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media\/14550"}],"wp:attachment":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media?parent=14549"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/categories?post=14549"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/tags?post=14549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}